Sarvodaya Cancer Hospital Delhi NCR proudly announces the first-time availability of Radium-223 therapy in India for patients with castration-resistant prostate cancer (CRPC) and predominant skeletal metastases. This milestone marks a new era in precision oncology, offering hope to patients with advanced…
A New Ray of Hope: Terbium-161 Therapy Now Available at Theranostics Centre a unit of Sarvodaya Hospital
Theranos Care unit of Sarvodaya Hospital, Faridabad has become the first center in the Indian subcontinent to offer Terbium-161 therapy in India for patients with metastatic castration-resistant prostate cancer (mCRPC) and metastatic neuroendocrine tumors (NET) who have not responded to Lutetium-PSMA…
Neuroendocrine Tumors: Symptoms, Causes, Risk Factors & Treatment
Neuroendocrine tumors (NETs) are a rare group of cancers that can grow in different parts of the body. They start in special cells called “neuroendocrine cells”, which help control how your body works by releasing hormones. These cells are found in…
Peptide Receptor Radionuclide Therapy PRRT Role in Neuroendocrine Cancer treatment
A Targeted Breakthrough in Treating Neuroendocrine Tumors By Using PRRT Being diagnosed with a neuroendocrine tumor (NET) can feel confusing and overwhelming. These rare tumors often grow slowly and may not cause symptoms for years. But when they do, they can…
Targeted Lu-177 (Lutetium) PSMA Therapy for Prostate Cancer: A New Hope for Men Fighting Advanced Disease
If you or a loved one is living with advanced prostate cancer, you may have heard about a new treatment called Lu-177 PSMA therapy. It’s one of the most promising breakthroughs in cancer care—and it’s changing lives by offering hope where…
Nuclear Medicine Therapy for Prostate Cancer: Options, Side Effects & Success Rates
If you or a loved one is facing advanced prostate cancer, you may have heard about new treatments using nuclear medicine or simply put, Theranostics. These therapies – Lutetium-177 (Lu-177), Actinium-225 (Ac-225), and Terbium-161 (Tb-161) – are offering new hope to…